DPT Facts
Psychedelic;
Description
DPT (N,N-dipropyltryptamine) is a synthetic psychedelic of the tryptamine class. It activates serotonin receptors and simultaneously floods the brain with stored serotonin[1][2] — a dual mechanism shared by no other classical psychedelic.
Subjective effects include geometric visual patterns, emotional warmth, a dissolving sense of self, deep introspective states, and heightened interpersonal connection. The experience blends classical psychedelic hallucination with empathogenic openness — clinical investigators consistently noted both qualities together,[3] distinguishing DPT from more purely visionary substances.
DPT does not produce physical dependence, and no pharmacological lethal dose has been established.[4] The primary risks are seizure at high doses and a life-threatening reaction when combined with MAO inhibitors or antidepressants, which amplify DPT's serotonin release to toxic levels.safety citation needed
Dose and durationby route · individual sensitivity varies
Starts in 20 – 60 minLasts 2 – 4 hoursAfter-effects 2 – 3 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- None
- Fully resets after
- Not recorded
- Carries over to
- DOI;
2C-T-7; LSD; psilocybin; mescaline
Effectslikely at a common dose
- Perception
- Color alteration;
Environmental patterning; Symmetrical texture repetition; Tracers; Color enhancement; Visual drifting; Ganzfeld effect; Geometry; Holotropic state; Visual breathing; Visual morphing; +26 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion - Body
- Spontaneous body sensations;
Pupil dilation; Wakefulness; Body high; Body scan awareness; +32 possible, including Motor control impairment, Muscle tension, Nausea - Thinking
- Conceptual thinking;
Novelty enhancement; Immersion enhancement; Confusion; Thought disorganization; Cognitive impairment; Decision impairment; Focus suppression; Introspection enhancement; +24 possible, including Language suppression, Thought loops, Memory suppression - Feeling
- Anxiety;
Emotional enhancement; +7 possible, including Dysphoria, Emotional lability, Paranoia - Self
- none likely · 8 possible, including Communication suppression, Depersonalization, Derealization
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- Personal insight;
+1 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Tyagi R, Saraf TS, Canal CE (2023) The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors. — ACS pharmacology & translational science doi:10.1021/acsptsci.3c00137
- [2]^Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. — Journal of neural transmission doi:10.1007/s00702-009-0308-8
- [3]^Grof S, Soskin RA, Richards WA, Kurland AA (1973) DPT as an adjunct in psychotherapy of alcoholics. — International pharmacopsychiatry PMID:4150711
- [4]^Neukamm MA, Pollak S, Thoma V, Vogt S, Huppertz LM, Auwärter V (2024) A fatal case of aspiration due to consumption of the hallucinogenic tryptamine derivative dipropyltryptamine (DPT). — Journal of pharmaceutical and biomedical analysis doi:10.1016/j.jpba.2023.115959